Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
A randomized non-inferiority study comparing the addition of exenatide twice daily to sitagliptin or switching from sitagliptin to exenatide twice daily in patients with type 2 diabetes experiencing inadequate glycaemic control on metformin and sitagliptin
Quality Indicators Third-party testing through Certificates of Analysis (COA) provides the most reliable quality indicator
This signaling reduces the desire to eat and promotes a feeling of fullness, leading to decreased food intake
Antioxidants 14(3):320
US$ 21.62
US$ 26.47
US$ 22.32
US$ 22.01
US$ 28.52
